Latest News

news article image

Discovery behind blockbuster Pfizer-Trillium deal started at UHN and SickKids.

March 22, 2022

A cancer research discovery made at the University Health Network and The Hospital for Sick Children has spurred a major pharmaceutical industry deal between Pfizer Inc. and Trillium Therapeutics

“Don’t Eat Me”. It’s a simple biological message whispered by crafty cancer cells to the immune system as they attempt to spread, grow and avoid destruction.

But the complex work to understand and control that signal which gives those dangerous cells the power to hide has taken decades of research to understand. Last year, the story took a new twist when it spurred pharmaceutical giant Pfizer Inc.’s acquisition of Trillium Therapeutics in a US$2.22 billion deal.

READ MORE
news article image

UHN Inventor of the Year

December 6, 2022

Drs. Heather Ross and Joseph Cafazzo are the winners of UHN's 19th annual Inventor of the Year Award.

The researchers are being recognized for their discovery leading to the commercialization of the Medly platform, a fit-in-your pocket companion for heart care powered by software and artificial intelligence developed at UHN.

Medly is also the basis of UHN new venture Medly Therapeutics, poised to bring heart care benefits to patients around the world.

READ MORE

Featured News

news article image
news article image
news article image

Industry News

news article image
news article image
news article image

Podcasts

podcast cover image

A podcast about the people behind world-leading research at UHN

Listen Now
podcast cover image

A new podcast from Krembil Brain Institute

Listen Now

UHN Newsroom

Archive